Actively Recruiting
Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
Led by Potomac Health Foundations · Updated on 2025-11-18
80
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Despite rising rates of fatal opioid overdoses in the United States, adolescents with OUD are far less likely than adults to receive and be retained on medication for opioid use disorder (MOUD). The multicomponent Youth Opioid Recovery Support (YORS) intervention for young adults seeks to increase adherence to extended-release MOUD and reduce opioid relapse through family involvement, assertive outreach, low-barrier access to MOUD, and contingency management. By expanding investigations of the evidence based YORS intervention to adolescents, especially those on sublingual buprenorphine, this project will significantly contribute to our knowledge base of practical strategies to address the opioid crisis in youth.
CONDITIONS
Official Title
Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 13 to 21 years inclusive
- Diagnosis of opioid use disorder (OUD)
- English speaking
- Willing to comply with all study procedures and YORS intervention
- Willing to have a legal, English-speaking guardian provide consent
- Presenting for inpatient or outpatient treatment with at least one day of opioid use in past 30 days
- Considering treatment with extended-release naltrexone, extended-release buprenorphine, or sublingual buprenorphine, or recently started sublingual buprenorphine maintenance within two weeks
- Willing to designate a parent, family member, or other person as Treatment Significant Other
- Access to a mobile phone
- Treatment Significant Other must be English speaking, willing to comply with study procedures, aged 18 or older, and have access to a mobile phone
You will not qualify if you...
- Psychiatric or medical instability that would prevent participation (e.g., suicidality, psychosis, frequent sickle cell crises)
- Living situation unsuitable for participation (e.g., living more than 75 miles from treatment center, homelessness)
- Treatment Significant Other currently sharing drugs with the adolescent participant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maryland Treatment Centers
Baltimore, Maryland, United States, 21229
Actively Recruiting
Research Team
K
Kevin Wenzel, PhD
CONTACT
M
Marc Fishman, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here